AAAAAA

   
Results: 1-22 |
Results: 22
Down-regulation of human B lymphocyte activities by a Trypanosoma cruzi membrane glycoprotein
Authors: Kierszenbaum, F Sztein, MB
Citation: F. Kierszenbaum et Mb. Sztein, Down-regulation of human B lymphocyte activities by a Trypanosoma cruzi membrane glycoprotein, INT J PARAS, 31(3), 2001, pp. 265-271
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915
Authors: Wang, JY Pasetti, MF Noriega, FR Anderson, RJ Wasserman, SS Galen, JE Sztein, MB Levine, MM
Citation: Jy. Wang et al., Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915, INFEC IMMUN, 69(8), 2001, pp. 4734-4741
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection
Authors: Kotloff, KL Sztein, MB Wasserman, SS Losonsky, GA DiLorenzo, SC Walker, RI
Citation: Kl. Kotloff et al., Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection, INFEC IMMUN, 69(6), 2001, pp. 3581-3590
Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains
Authors: Gomez-Duarte, OG Pasetti, MF Santiago, A Sztein, MB Hoffman, SL Levine, MM
Citation: Og. Gomez-duarte et al., Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains, INFEC IMMUN, 69(2), 2001, pp. 1192-1198
Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
Authors: Tacket, CO Galen, J Sztein, MB Losonsky, G Wyant, TL Nataro, J Wasserman, SS Edelman, R Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C, CLIN IMMUNO, 97(2), 2000, pp. 146-153
A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model
Authors: Pasetti, MF Pickett, TE Levine, MM Sztein, MB
Citation: Mf. Pasetti et al., A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model, VACCINE, 18(28), 2000, pp. 3208-3213
Delta guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin
Authors: Anderson, RJ Pasetti, MF Sztein, MB Levine, MM Noriega, FR
Citation: Rj. Anderson et al., Delta guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin, VACCINE, 18(21), 2000, pp. 2193-2202
Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C
Authors: Wu, SG Beier, M Sztein, MB Galen, J Pickett, T Holder, AA Gomez-Duarte, OG Levine, MM
Citation: Sg. Wu et al., Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C, J BIOTECH, 83(1-2), 2000, pp. 125-135
Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000)
Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-y and IL-10 to Shigella invasions by mononuclear cells from volunteers orally inoculated with a shiga toxin-deleted Shigella dysenteriae type 1 strain (vol 164, pg 2221, 2000), J IMMUNOL, 165(8), 2000, pp. 4756-4756
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain
Authors: Samandari, T Kotloff, KL Losonsky, GA Picking, WD Sansonetti, PJ Levine, MM Sztein, MB
Citation: T. Samandari et al., Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain, J IMMUNOL, 164(4), 2000, pp. 2221-2232
Role of EspB in experimental human enteropathogenic Escherichia coli infection
Authors: Tacket, CO Sztein, MB Losonsky, G Abe, A Finlay, BB McNamara, BP Fantry, GT James, SP Nataro, JP Levine, MM Donnenberg, MS
Citation: Co. Tacket et al., Role of EspB in experimental human enteropathogenic Escherichia coli infection, INFEC IMMUN, 68(6), 2000, pp. 3689-3695
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans
Authors: Kotloff, KL Noriega, FR Samandari, T Sztein, MB Losonsky, GA Nataro, JP Picking, WD Barry, EM Levine, MM
Citation: Kl. Kotloff et al., Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans, INFEC IMMUN, 68(3), 2000, pp. 1034-1039
Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers
Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors
Authors: Pickett, TE Pasetti, MF Galen, JE Sztein, MB Levine, MM
Citation: Te. Pickett et al., In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors, INFEC IMMUN, 68(1), 2000, pp. 205-213
Shigella, Salmonella typhi, and Escherichia coli: Effects of microbes on the immune system
Authors: Levine, MM Sztein, MB
Citation: Mm. Levine et Mb. Sztein, Shigella, Salmonella typhi, and Escherichia coli: Effects of microbes on the immune system, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, 2000, pp. 171-194
Attenuated Delta guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses
Authors: Pasetti, MF Anderson, RJ Noriega, FR Levine, MM Sztein, MB
Citation: Mf. Pasetti et al., Attenuated Delta guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses, CLIN IMMUNO, 92(1), 1999, pp. 76-89
Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes
Authors: Wyant, TL Tanner, MK Sztein, MB
Citation: Tl. Wyant et al., Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes, INFEC IMMUN, 67(7), 1999, pp. 3619-3624
Differential expression of Vibrio vulnificus capsular polysaccharide
Authors: Wright, AC Powell, JL Tanner, MK Ensor, LA Karpas, AB Morris, JG Sztein, MB
Citation: Ac. Wright et al., Differential expression of Vibrio vulnificus capsular polysaccharide, INFEC IMMUN, 67(5), 1999, pp. 2250-2257
Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells
Authors: Wyant, TL Tanner, MK Sztein, MB
Citation: Tl. Wyant et al., Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells, INFEC IMMUN, 67(3), 1999, pp. 1338-1346
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA
Authors: Galen, JE Nair, J Wang, JK Wasserman, SS Tanner, MK Sztein, MB Levine, MM
Citation: Je. Galen et al., Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA, INFEC IMMUN, 67(12), 1999, pp. 6424-6433
Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 onthe expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes
Authors: Kierszenbaum, F de Diego, JL Fresno, M Sztein, MB
Citation: F. Kierszenbaum et al., Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 onthe expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes, EUR J IMMUN, 29(5), 1999, pp. 1684-1691
Vasculitis in the Palmerston North mouse model of lupus - Phenotype and cytokine production profile of infiltrating cells
Authors: Luzina, IG Knitzer, RH Atamas, SP Gause, WC Papadimitriou, JC Sztein, MB Storrer, CE Handwerger, BS
Citation: Ig. Luzina et al., Vasculitis in the Palmerston North mouse model of lupus - Phenotype and cytokine production profile of infiltrating cells, ARTH RHEUM, 42(3), 1999, pp. 561-568
Risultati: 1-22 |